The results showed that CD4+ T cells of RA patients produced significantly higher levels of IL-17A and IFN-γ compared with HCs when stimulated with anti-CD3 and anti-CD28 (Fig. 3A,B,D,E). The gene discussed is CD4; the disease is rheumatoid arthritis.